Skip to content

Bristol-Myers Squibb Completes Acquisition of Amylin Pharmaceuticals, Inc.

August 9th, 2012
Bristol-Myers Squibb Company announced today that it has completed its previously announced acquisition of Amylin Pharmaceuticals. PDF


Challenging Science. Changing Lives.

Amylin Pharmaceuticals is an exceptional company of extraordinary people. Their willingness to challenge conventional thinking as much as they challenge themselves, their resolve, resiliency and passion for the patient are improving the lives of millions.

Announcements

  • August 9th, 2012
    Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through
    Bristol-Myers Squibb’s Acquisition of Amylin. PDF
  • August 9th, 2012
    Bristol-Myers Squibb Completes Acquisition of Amylin Pharmaceuticals, Inc. PDF
  • August 8th, 2012
    Bristol-Myers Squibb Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc. PDF